Coherus BioSciences Newsroom

Truist Financial Initiates Coherus BioSciences(CHRS.US) With Buy Rating

Futu NewsNov 19 20:33

Barclays Maintains Coherus BioSciences(CHRS.US) With Buy Rating, Maintains Target Price $7

Futu NewsNov 18 17:33

Coherus Biosciences (CHRS) Receives a Buy From Barclays

TipRanksNov 18 17:25

Baird Maintains Coherus BioSciences(CHRS.US) With Buy Rating, Cuts Target Price to $4

Futu NewsNov 8 20:35

Baird Maintains Outperform on Coherus BioSciences, Lowers Price Target to $4

BenzingaNov 8 20:28

TD Cowen Maintains Coherus BioSciences(CHRS.US) With Buy Rating

Futu NewsNov 7 22:35

Coherus Biosciences: Strong Financial Performance and Strategic Cost Management Drive Buy Rating

TipRanksNov 7 22:09

Coherus BioSciences Analyst Ratings

BenzingaNov 7 19:25

Truist Financial Maintains Coherus BioSciences(CHRS.US) With Buy Rating

Futu NewsOct 16 15:31

Analysts Offer Insights on Healthcare Companies: Jasper Therapeutics (JSPR) and Coherus Biosciences (CHRS)

TipRanksOct 16 15:05

JonesTrading Maintains Coherus BioSciences(CHRS.US) With Buy Rating

Futu NewsOct 8 18:32

Baird Maintains Coherus BioSciences(CHRS.US) With Buy Rating, Maintains Target Price $8

Futu NewsSep 17 08:31

Coherus BioSciences Analyst Ratings

BenzingaSep 16 19:58

HC Wainwright & Co. Reiterates Buy on Coherus BioSciences, Maintains $12 Price Target

BenzingaSep 16 19:58

Truist Financial Maintains Coherus BioSciences(CHRS.US) With Buy Rating

Futu NewsSep 16 19:31

H.C. Wainwright Maintains Coherus BioSciences(CHRS.US) With Buy Rating, Maintains Target Price $12

Futu NewsSep 16 18:31

Maintaining Buy Rating on Coherus Biosciences Amid Temporarily Disrupted Supply Chain

TipRanksSep 16 18:20

Barclays Maintains Coherus BioSciences(CHRS.US) With Buy Rating, Maintains Target Price $7

Futu NewsAug 19 20:33

Barclays Keeps Their Buy Rating on Coherus Biosciences (CHRS)

TipRanksAug 19 20:18

UBS Cuts Coherus to Neutral, Cites Limited Growth Opportunities

Seeking AlphaAug 17 04:32